Gemma Tell

Publicacions destacades

  • Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS mutations

    Autors: Martins da Silva V, Martinez-Barrios E, Tell-Martí G, Dabad M, Carrera C, Aguilera P, Brualla D, Esteve-Codina A, Vicente A, Puig S, Puig-Butillé JA, Malvehy J .
    Referència: JOURNAL OF INVESTIGATIVE DERMATOLOGY 2019; 139(4):900-908.
  • Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.

    Autors: Vallone MG, Tell-Marti G, Potrony M, Rebollo-Morell A, Badenas C, Puig-Butille JA, Gimenez-Xavier P, Carrera C, Malvehy J, Puig S .
    Referència: PIGMENT CELL AND MELANOMA RESEARCH 2018; 31(1):39-50.
  • The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington’s Disease Patients

    Autors: Tell-Marti G., Puig-Butille J., Gimenez-Xavier P., Segu-Roig A., Potrony M., Badenas C., Alvarez V., Millán J., Trujillo-Tiebas M., Ramos-Arroyo M., Milà M., Puig S..
    Referència: MOLECULAR NEUROBIOLOGY 2017.
  • IRF4 rs12203592 functional variant and melanoma survival.

    Autors: Potrony M, Rebollo-Morell A, Giménez-Xavier P, Zimmer L, Puig-Butille JA, Tell-Marti G, Sucker A, Badenas C, Carrera C, Malvehy J, Schadendorf D, Puig S .
    Referència: INTERNATIONAL JOURNAL OF CANCER 2017.
  • Genomic expression differences between cutaneous cells from red hair color individuals and black hair color individuals based on bioinformatic analysis

    Autors: Puig-Butille JA, Gimenez-Xavier P, Visconti A, Nsengimana J, Garcia-García F, Tell-Marti G, Escamez MJ, Newton-Bishop J, Bataille V, Del Río M, Dopazo J, Falchi M, Puig S .
    Referència: ONCOTARGET 2017.
  • AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy.

    Autors: Puig-Butille JA, Vinyals A, Ferreres JR, Aguilera P, Cabré E, Tell-Martí G, Marcoval J, Mateo F, Palomero L, Badenas C, Piulats JM, Malvehy J, Pujana MA, Puig S, Fabra À .
    Referència: JOURNAL OF INVESTIGATIVE DERMATOLOGY 2017.
  • A Common Variant in the MC1R Gene (p

    Autors: Tell-Marti G, Puig-Butille JA, Potrony M, Plana E, Badenas C, Antonell A, Sanchez-Valle R, Molinuevo JL, Lleó A, Alcolea D, Fortea J, Fernández-Santiago R, Clarimón J, Lladó A, Puig S .
    Referència: 2017.
  • Mutational status of naevus-associated melanomas

    Autors: Shitara, D; Tell-Marti, G; Badenas, C; Enokihara, M M S S; Alos, L; Larque, A B; Michalany, N; Puig-Butille, J A; Carrera, C; Malvehy, J; Puig, S; Bagatin, E.
    Referència: BRITISH JOURNAL OF DERMATOLOGY 2015.
  • Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer

    Autors: Puig-Butille, Joan Anton; Escamez, Maria Jose; Garcia-Garcia, Francisco; Tell-Marti, Gemma; Fabra, Angels; Martinez-Santamaria, Lucia; Badenas, Celia; Aguilera, Paula; Pevida, Marta; Dopazo, Joaquin; del Rio, Marcela; Puig, Susana.
    Referència: ONCOTARGET 2014.

Projectes destacats

  • Implementation of personalized medicine in cutaneous melanoma based on genomic susceptibility and tumor signatures: Identification of new targets for melanoma treatment.

    Investigador/a principal: Marti R
    Finançador: FUNDACIÓ LA MARATÓ DE TV3
    Durada: 15/05/2014 - 31/12/2017
  • Evaluation of immunologic alterations underling development, progression and immunologic therapies response in melanoma. Implications of the microbiome in the tolerance induction and immuno-related adverse events in immunologic therapies.

    Investigador/a principal: Puig S
    Finançador: INSTITUTO DE SALUD CARLOS III
    Durada: 01/01/2016 - 31/12/2018
  • Distinct routes of metastatic dissemination in different melanoma subtypes. Implications in the validation of new tumor biomarkers and therapeutic targets.

    Investigador/a principal: Piulats JM
    Finançador: ASOCIACIÓN ESPAÑOLA CONTRA EL CÁNCER
    Durada: 07/01/2015 - 30/06/2020
  • Papel del estrés oxidativo en el desarrollo del Melanoma Familiar y otras ER comunes con predisposición al desarrollo de neoplasias cutáneas

    Finançador: CIBER ENFERMEDADES RARAS (CIBERER)
    Durada: 01/01/2015 - 31/12/2015
  • Phenotype and molecular characterization of Large to Giant Congenital Melanocytic Nevi.

    Investigador/a principal: Puig-Butille JA
    Finançador: FUNDACIÓN TODOS SOMOS RAROS
    Durada: 01/01/2015 - 31/12/2016